Clinical trials: Aldosteronism
Primary Aldosteronism, Resistant Hypertension
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
Primary aldosteronism (PA) is common but rarely recognized cause of hypertension that carries excess cardiovascular and renal risk and has approved targeted treatments.
- Conditions
- Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension, Hyperaldosteronism
- Trial name
- ALERT-PA (NCT05925569)
- Testing
- Best Practice Advisory Computerized Alert
- Where
- United States
- Volunteers
- 12,501 people
- Sponsor
- Brigham and Women's Hospital
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism
This study was a single-center randomized controlled trial which lasted 14 days and consisted of two stages (run-in period (stage I) and intervention period (stage II) each contain 7 days without potassium supplement.
- Trial name
- NCT05649631
- Testing
- Sodium
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Primary Aldosteronism
Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
The project is aimed to determine the value of synacthen infusion on the results of adrenal venous sampling in patients examined for primary aldosteronism
- Trial name
- ISIRA (NCT02127840)
- Testing
- Synacthen infusion during adrenal venous sampling
- Where
- Czechia
- Volunteers
- 40 people
- Sponsor
- Charles University, Czech Republic
Primary Aldosteronism
The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism
In this prospective controlled trial, we aim to determine whether superselective adrenal artery embolization is superior to medical treatment for patients with PA who refuse surgery for medication.
- Trial name
- NCT05262660
- Where
- China
- Volunteers
- 400 people
- Sponsor
- First Affiliated Hospital of Chengdu Medical College
Primary Hyperaldosteronism, Secondary Hyperaldosteronism
Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism
Animal models have demonstrated the role of aldosterone in left ventricular remodeling involving fibrosis, apoptosis and hypertrophy.
- Conditions
- Primary Hyperaldosteronism, Secondary Hyperaldosteronism, Essential Hypertension, Healthy
- Trial name
- COEURALDO (NCT02938910)
- Testing
- non interventional study
- Where
- France
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Primary Aldosteronism, Hypertension
Steroids-Based Screening for Primary Aldosteronism
This prospective, single-center observational study aims to evaluate whether a steroid-based screening method can more accurately identify Primary Aldosteronism (PA) in hypertensive patients who remain on their usual…
- Trial name
- SAFE (NCT06941116)
- Testing
- Steroid-Based Screening (LC-MS/MS)
- Where
- China
- Volunteers
- 406 people
- Sponsor
- Qifu Li
Primary Aldosteronism, Hypertension
Overnight Dexamethasone in Primary Aldosteronism Screening
The goal of this observational study is to learn whether screening for primary aldosteronism can be improved among patients on chronic blood pressure-lowering medications by ordering intake of 1 mg of dexamethasone prior to…
- Trial name
- ODEPRASC (NCT06740838)
- Where
- Poland
- Volunteers
- 240 people
- Sponsor
- Medical University of Gdansk
Adrenal Gland Neoplasm, Hypertension
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Background: The adrenal gland makes the hormone aldosterone. This helps regulate blood pressure. An adrenal gland tumor that makes too much aldosterone can cause high blood pressure and low potassium.
- Conditions
- Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic, Cardiovascular Disease
- Trial name
- NCT03374215
- Where
- United States
- Volunteers
- 1,150 people, healthy volunteers welcome
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hyperaldosteronism Primary
Is the Evolution of the Aldosterone-renin Ratio Pre- Versus Post-operative on Day 1 Following Unilateral Adrenalectomy for Primary Hyperaldosteronism Predictive of Blood Pressure Outcomes
Primary hyperaldosteronism is characterised by excessive and autonomous aldosterone secretion by the adrenal glands, independent of renin.
- Trial name
- vRAR (NCT07110155)
- Volunteers
- 110 people
- Sponsor
- Central Hospital, Nancy, France
Primary Aldosteronism
Preoperative Supine Time for Adrenal Venous Sampling
This study aim to understand whether the length of preoperative supine time would affect the AVS outcome.
- Trial name
- PSTAVS (NCT05658705)
- Testing
- 15-min supine time, 2-hour supine time
- Where
- China
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Primary Aldosteronism, Hypertension
Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
This research study aims to learn more about the impact the hormone aldosterone on the heart. Primary aldosteronism is a condition where the body's adrenal glands make too much of the hormone aldosterone, which can cause high…
- Trial name
- NCT05030545
- Testing
- Eplerenone
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Brigham and Women's Hospital
Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Diagnostic Value of 68Ga-Pentixafor PET/CT in Adrenal Tumors With Aldosterone and Cortisol Cosecretion
The goal of this observational study is to evaluate the diagnostic accuracy of 68 68 Ga-Pentixafor-CXCR4 PET/CT in identifying the dominant side of hormone excess in adult patients (aged 18-80 years) with primary aldosteronism…
- Trial name
- NCT07605156
- Where
- China
- Volunteers
- 130 people
- Sponsor
- Peking University First Hospital
Hypertension
Virtual Twins as Tools for Personalized Clinical Care in Renal Denervation - Pilot Study
High blood pressure (hypertension) is a common condition. Despite the availability of several medications, many patients continue to have poorly controlled blood pressure.
- Trial name
- VITAL-RDN (NCT07462572)
- Testing
- Data collection in order to train the digital twin
- Where
- 2 sites in France
- Volunteers
- 60 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Primary Aldosteronism
Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
1. Aim to investigate the pathological feature of UPA in Asians 2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians. 3.
- Trial name
- NCT06597630
- Testing
- Tissue specimens were stained by histopathology of hematoxylin-eosin
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Qifu Li
Primary Aldosteronism, Hypertension
Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism
Primary aldosteronism (PA) is the main cause of secondary hypertension, affecting 5-15% of the general hypertensive population. Early diagnosis and treatment are of crucial importance as patients with PA are more susceptible to…
- Trial name
- NCT04269928
- Testing
- Endovascular chemical ablation of adrenal gland
- Where
- China
- Volunteers
- 110 people
- Sponsor
- Third Military Medical University
Primary Aldosteronism
Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA
The primary objective of WAVE is to test the hypothesis that thermal ablation (microwave or RFA) is non-inferior to surgery in the biochemical (and if so, in the clinical) cure of unilateral PA, according to the international…
- Trial name
- WAVE (NCT05405101)
- Testing
- Thermal ablation of aldosterone producing adenoma., Unilateral adrenalectomy
- Where
- 6 sites in United Kingdom
- Volunteers
- 112 people
- Sponsor
- Queen Mary University of London
Subclinical Primary Aldosteronism
Early Aldo Blockade in Subclinical PA
This trial aims to evaluate the preventive effect of early intervention with eplerenone, a highly selective nonsteroidal mineralocorticoid receptor antagonist, against new-onset hypertension in normotensive patients with…
- Trial name
- EARLY-PA (NCT07727252)
- Testing
- Eplerenone
- Volunteers
- 880 people
- Sponsor
- Xinjiang Medical University
Hyperaldosteronism, Hypertension
Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure
Some patients with high blood pressure can experience an increase of blood pressure by 10 percent or more by taking in salt. These patients are referred to as having "salt-sensitive" (SS) hypertension.
- Trial name
- NCT00001176
- Where
- United States
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Apparent Mineralocorticoid Excess (AME)
The Role of Mineralocorticoid Receptors in Vascular Function
The purpose of this study is to figure out how decreasing the activity of 11-beta hydroxysteroid dehydrogenase (11-beta HSD) will affect your blood vessel function.
- Trial name
- NCT00759525
- Testing
- Glycyrrhetic Acid
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Brigham and Women's Hospital
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather
Primary aldosteronism (PA) is the most common endocrine cause of hypertension. 68Ga-pentixafor PET/CT possesses a relatively high sensitivity and specificity for Aldosterone producing adenoma (APA) detection.
- Trial name
- NCT06581744
- Testing
- [18F]AlF-NOTA-Pentixather
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Fangfang Sun